Stocks VREOF Financial statements
Financial statementsVireo Growth Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Vireo Growth Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Revenue | 49.2 | 54.4 | 74.6 | 88.1 | 99.4 | 269 |
| Cost of revenue | 31.1 | 32 | 39.4 | |||
| Gross profit | 17.1 | 19.8 | 30.9 | 44.1 | 50.8 | 127 |
| Selling, general and administrative | 26.4 | 33.7 | 33.8 | 28.2 | 28.1 | 81.2 |
| Operating expenses | 40.2 | 40.3 | 37.8 | 33.5 | 37.2 | 128 |
| Operating income | -23 | -20.5 | -6.94 | 10.6 | 13.6 | -1.05 |
| Interest expense | 5.1 | 10.6 | 22.6 | 31.3 | 31.2 | |
| Other non-operating income | 8.89 | -9.09 | -29.6 | -28.4 | -30.5 | -38.9 |
| Pre-tax income | -14.2 | -29.6 | -36.6 | -17.8 | -16.9 | -39.9 |
| Income tax | 8.79 | 4.12 | 5.89 | 7.72 | 11.1 | 28.2 |
| Net income | -22.9 | -33.7 | -42.5 | -25.5 | -28 | -68.1 |
| EBITDA | -20.6 | -17.5 | -3.6 | 13.5 | 16.1 | 15.1 |
| EPS, basic | -0.24 | -0.27 | -0.33 | -0.19 | -0.16 | -0.09 |
| EPS, diluted | -0.24 | -0.27 | -0.33 | -0.19 | -0.16 | -0.09 |
| Shares, basic (weighted) | 97.6 | 124 | 128 | 135 | 180 | 735 |
| Shares, diluted (weighted) | 97.6 | 124 | 128 | 135 | 180 | 735 |
Balance sheet
| FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Cash and equivalents | 27.1 | 15.2 | 15.1 | 16 | 91.6 | 123 |
| Short-term investments | 1 | |||||
| Receivables | 0.7 | 4.5 | 4.29 | 2.26 | 2.87 | 12.7 |
| Inventory | 12.6 | 20.4 | 20.5 | 19.3 | 21.7 | 60 |
| Other current assets | 1.55 | 1.56 | 2.54 | 1.34 | 1.65 | 3.8 |
| Total current assets | 47 | 41.6 | 46.7 | 149 | 230 | 305 |
| Property, plant and equipment | 30.6 | 99.5 | 89.6 | 23.3 | 32.3 | 218 |
| Lease right-of-use assets | 8.16 | 8.51 | 6.11 | 2.02 | 7.86 | 53.4 |
| Goodwill | 3.13 | 0.18 | 0.18 | 0 | 0 | 87.5 |
| Intangible assets | 8.41 | 10.2 | 8.78 | 8.72 | 7.9 | 118 |
| Long-term investments | 6 | |||||
| Total assets | 103 | 167 | 159 | 183 | 279 | 817 |
| Accounts payable | 0.9 | 1.49 | 1.91 | 1.77 | 2.3 | 19 |
| Accrued liabilities | 5.11 | 7.71 | 6.17 | 4.85 | 6.84 | 26.6 |
| Deferred revenue | 0.24 | 0.41 | 0.68 | 0.83 | 1.05 | 4.7 |
| Short-term debt | 1.11 | 11.8 | ||||
| Total current liabilities | 19.9 | 16.4 | 29.7 | 179 | 135 | 192 |
| Long-term debt | 0 | 27.3 | 46.2 | |||
| Lease liabilities | 50.5 | |||||
| Other non-current liabilities | 0.16 | 0.04 | 1 | |||
| Total liabilities | 40.3 | 124 | 156 | 199 | 223 | 510 |
| Total debt | 1.11 | 27.3 | 58 | |||
| Paid-in capital | 164 | 178 | 181 | 187 | 287 | 607 |
| Retained earnings | -102 | -135 | -178 | -203 | -231 | -300 |
| Shareholders' equity | 62.3 | 43 | 3.44 | -16 | 55.5 | 307 |
| Total equity | 62.3 | 43 | 3.44 | -16 | 55.5 | 307 |
| Total liabilities and equity | 103 | 167 | 159 | 183 | 279 | 817 |
Cash flow statement
| FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Net income | -22.9 | -33.7 | -42.5 | -25.5 | -28 | -68.1 |
| Depreciation and amortization | 2.48 | 3.03 | 3.34 | 2.87 | 2.54 | 16.1 |
| Stock-based compensation | 12.8 | 5.18 | 2.69 | 4.16 | 3.63 | 18.7 |
| Deferred income tax | 1.36 | -1.34 | -0.19 | 1.69 | -13.4 | |
| Change in receivables | -0.4 | -3.49 | 0.23 | 1.45 | -1.03 | -6.06 |
| Change in inventory | -2.66 | -10.3 | -3.99 | -1.82 | -2.39 | -8.7 |
| Change in payables | 8.68 | 2.65 | -0.77 | -1.26 | 2.4 | -8.72 |
| Cash from operations | -10.9 | -30.5 | -18.1 | -0.97 | -10.2 | 3.71 |
| Capital expenditures | -8.45 | -18 | -5.56 | -4.96 | -11.7 | -28.3 |
| Cash from investing | 12.9 | -7.21 | -5.62 | -3.48 | -8.13 | 8.76 |
| Debt issued | 27.1 | 25.8 | ||||
| Debt repaid | 0 | -0.06 | 0 | |||
| Stock issued | 0.09 | 1.21 | 0.01 | 0.02 | 0.12 | |
| Cash from financing | 15.9 | 25.8 | 23.7 | 5.26 | 94 | 18.4 |
| Net change in cash | 17.9 | -12 | -0.01 | 0.82 | 75.6 | 30.9 |
| Free cash flow | -19.4 | -48.6 | -23.6 | -5.93 | -21.9 | -24.6 |
| Interest paid | 5.86 | 6.86 | 16.6 | 25 | 27.2 | 28.6 |
| Income taxes paid | 0.37 | 5.89 | 5.13 | 2.04 | 1.02 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 48.6% | Gross profit / revenue. |
| Operating margin | 0.3% | Operating income / revenue. |
| EBITDA margin | 4.7% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -2.9% | Pre-tax income / revenue. |
| Net margin | -13.1% | Net income / revenue. |
| FCF margin | -22.7% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 5.1% | Cash from operations / revenue. |
| Return on equity (ROE) | -15.2% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -5.3% | Net income / average total assets. |
| Return on invested capital (ROIC) | 0.4% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 32.8% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 5.4% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 27.9% | Capital expenditures / revenue. |
| D&A / revenue | 4.4% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 170.4% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 53.3% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 40.4% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 150.3% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 60.2% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 49.3% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | -107.7% | Operating income vs the same period a year earlier. Only from a positive base. |
| EBITDA growth, 1y | -6.5% | EBITDA vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | 453.9% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 347.0% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 37.6% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 193.0% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 72.5% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 51.4% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 307.3% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 79.0% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 49.8% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.01x | Current assets / current liabilities. |
| Quick ratio | 0.32x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.32x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 65.3% | Total liabilities / total assets. |
| Working capital | $3.8M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 29.8% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $62.7M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.40x | Revenue / average total assets. |
| Fixed asset turnover | 1.82x | Revenue / average property, plant and equipment. |
| Capex / operating cash flow | 543.7% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$1.49 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $11.35 | Revenue / diluted weighted shares. |
| FCF per share | -$2.58 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.58 | Cash from operations / diluted weighted shares. |
| Book value per share | $9.81 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $1.39 | Tangible book value / shares outstanding. |
| Cash per share | $2.74 | (Cash + short-term investments) / shares outstanding. |
What was Vireo Growth Inc.'s revenue in fiscal 2025?
Vireo Growth Inc. reported revenue of $268.8M for fiscal 2025, 170.4% higher than the year before.
Was Vireo Growth Inc. profitable in fiscal 2025?
No. It reported a net loss of $68.1M.
How much free cash flow did Vireo Growth Inc. generate in fiscal 2025?
Cash from operations of $3.7M minus capital expenditures of $28.3M left free cash flow of -$24.6M.